.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia
. Ed(S): Morganroth, Joel; Moore, E. Neil
€ 193.57
FREE Delivery in Ireland
Description for Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia
Paperback. Proceedings of the Tenth Annual Symposium on New Drugs and Devices, October 31-November 1, 1989 Editor(s): Morganroth, Joel; Moore, E. Neil. Series: Developments in Cardiovascular Medicine. Num Pages: 230 pages, biography. BIC Classification: MJD. Category: (G) General (US: Trade). Dimension: 235 x 155 x 13. Weight in Grams: 379.
The Symposium on New Drugs provides for an annual forum for academic investigators, research and development personnel from the pharmaceutical and related health care industries, and members of the Food and Drug Administration to discuss important clinical research issues. The Tenth Annual Symposium on New Drugs addressed the problem of whether it was still appropriate to approve antihypertensive agents soley on the endpoint of lowering cuff blood pressure. The initial discussions at this symposium related to the approaches and methods to studying antihypertensive agents. Dr. William Frishman provided a detailed list of the new approaches to the treatment of hypertension ... Read more
The Symposium on New Drugs provides for an annual forum for academic investigators, research and development personnel from the pharmaceutical and related health care industries, and members of the Food and Drug Administration to discuss important clinical research issues. The Tenth Annual Symposium on New Drugs addressed the problem of whether it was still appropriate to approve antihypertensive agents soley on the endpoint of lowering cuff blood pressure. The initial discussions at this symposium related to the approaches and methods to studying antihypertensive agents. Dr. William Frishman provided a detailed list of the new approaches to the treatment of hypertension ... Read more
Product Details
Format
Paperback
Publication date
2011
Publisher
Springer-Verlag New York Inc. United States
Number of pages
230
Condition
New
Series
Developments in Cardiovascular Medicine
Number of Pages
230
Place of Publication
New York, NY, United States
ISBN
9781461288091
SKU
V9781461288091
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia